1. Home
  2. RFL vs BDSX Comparison

RFL vs BDSX Comparison

Compare RFL & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • BDSX
  • Stock Information
  • Founded
  • RFL 2017
  • BDSX 2005
  • Country
  • RFL United States
  • BDSX United States
  • Employees
  • RFL N/A
  • BDSX N/A
  • Industry
  • RFL Real Estate
  • BDSX Precision Instruments
  • Sector
  • RFL Finance
  • BDSX Health Care
  • Exchange
  • RFL Nasdaq
  • BDSX Nasdaq
  • Market Cap
  • RFL 54.4M
  • BDSX 53.0M
  • IPO Year
  • RFL N/A
  • BDSX 2020
  • Fundamental
  • Price
  • RFL $1.22
  • BDSX $7.53
  • Analyst Decision
  • RFL
  • BDSX Strong Buy
  • Analyst Count
  • RFL 0
  • BDSX 5
  • Target Price
  • RFL N/A
  • BDSX $32.50
  • AVG Volume (30 Days)
  • RFL 86.8K
  • BDSX 90.4K
  • Earning Date
  • RFL 12-10-2025
  • BDSX 11-03-2025
  • Dividend Yield
  • RFL N/A
  • BDSX N/A
  • EPS Growth
  • RFL N/A
  • BDSX N/A
  • EPS
  • RFL N/A
  • BDSX N/A
  • Revenue
  • RFL $917,000.00
  • BDSX $80,173,000.00
  • Revenue This Year
  • RFL N/A
  • BDSX $19.04
  • Revenue Next Year
  • RFL N/A
  • BDSX $26.39
  • P/E Ratio
  • RFL N/A
  • BDSX N/A
  • Revenue Growth
  • RFL 43.96
  • BDSX 22.29
  • 52 Week Low
  • RFL $1.19
  • BDSX $3.44
  • 52 Week High
  • RFL $3.19
  • BDSX $32.20
  • Technical
  • Relative Strength Index (RSI)
  • RFL 30.42
  • BDSX 54.99
  • Support Level
  • RFL $1.19
  • BDSX $6.40
  • Resistance Level
  • RFL $1.29
  • BDSX $8.52
  • Average True Range (ATR)
  • RFL 0.06
  • BDSX 0.72
  • MACD
  • RFL -0.00
  • BDSX -0.09
  • Stochastic Oscillator
  • RFL 7.69
  • BDSX 55.70

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: